Global Cell Dissociation Market to reach USD 575 million by 2025.

Global Cell Dissociation Market valued approximately USD 189,9 million in 2016 is anticipated to grow with a healthy growth rate of more than 13.1% over the forecast period 2017-2025. Factors that are the driving force for growth of this market include rising government funding for chronic disease research and increasing R&D investment in pharmaceutical & biotechnology companies. On the other hand, emerging economies such as China, India, and Brazil are providing ample of opportunities for the players operating in cell dissociation market.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

  • By Tissue:
  • Connective Tissue
  • Epithelial Tissue
  • Other Tissue
  • By Type:
  • Tissue Dissociation
  • Cell Detachment
  • By End User:
  • Pharmaceutical & Biotechnological Companies
  • Research & Academic Institutes
  • Other End Users

By Regions:

  • North America

o U.S.
o Canada

  • Europe

o UK
o Germany

  • Asia Pacific

o China
o India
o Japan

  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are ATCC, BD, F. Hoffmann-La Roche Ltd, GE Healthcare, HI media Laboratories, Merck KGAA, Miltenyi Biotec, Pan-Biotech, Stem cell Technologies, Thermo Fisher Scientific. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Cell Dissociation in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors